{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:56:04Z","timestamp":1777395364999,"version":"3.51.4"},"reference-count":281,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,5,18]]},"abstract":"<jats:p>The worldwide prevalence of sporadic (late-onset) Alzheimer\u2019s disease (sAD) is dramatically increasing. Aging and genetics are important risk factors, but systemic and environmental factors contribute to this risk in a still poorly understood way. Within the frame of BioMed21, the Adverse Outcome Pathway (AOP) concept for toxicology was recommended as a tool for enhancing human disease research and accelerating translation of data into human applications. Its potential to capture biological knowledge and to increase mechanistic understanding about human diseases has been substantiated since. In pursuit of the tau-cascade hypothesis, a tau-driven AOP blueprint toward the adverse outcome of memory loss is proposed. Sequences of key events and plausible key event relationships, triggered by the bidirectional relationship between brain cholesterol and glucose dysmetabolism, and contributing to memory loss are captured. To portray how environmental factors may contribute to sAD progression, information on chemicals and drugs, that experimentally or epidemiologically associate with the risk of AD and mechanistically link to sAD progression, are mapped on this AOP. The evidence suggests that chemicals may accelerate disease progression by plugging into sAD relevant processes. The proposed AOP is a simplified framework of key events and plausible key event relationships representing one specific aspect of sAD pathology, and an attempt to portray chemical interference. Other sAD-related AOPs (e.g., A\u03b2-driven AOP) and a better understanding of the impact of aging and genetic polymorphism are needed to further expand our mechanistic understanding of early AD pathology and the potential impact of environmental and systemic risk factors.<\/jats:p>","DOI":"10.3233\/jad-201418","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T13:01:07Z","timestamp":1617714067000},"page":"459-485","source":"Crossref","is-referenced-by-count":8,"title":["A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer\u2019s Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants"],"prefix":"10.1177","volume":"81","author":[{"given":"Maria","family":"Tsamou","sequence":"first","affiliation":[{"name":"ToxGenSolutions, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Pistollato","sequence":"additional","affiliation":[{"name":"European Commission, Joint Research Centre (JRC), Ispra, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin L.","family":"Roggen","sequence":"additional","affiliation":[{"name":"ToxGenSolutions, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-201418_ref2","doi-asserted-by":"crossref","unstructured":"Kerchner GA , Wyss-Coray T (2016) The role of aging in Alzheimer\u2019s disease. In Advances in Geroscience, Sierra F, Kohanski R, eds. Springer, Cham, pp. 197\u2013227.","DOI":"10.1007\/978-3-319-23246-1_7"},{"key":"10.3233\/JAD-201418_ref3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/1567205012666150204121719","article-title":"Role of environmental contaminants in the etiology of Alzheimer\u2019s disease: A review","volume":"12","author":"Yegambaram","year":"2015","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-201418_ref5","doi-asserted-by":"crossref","first-page":"e015746","DOI":"10.1136\/bmjopen-2016-015746","article-title":"Signs and symptoms preceding the diagnosis of Alzheimer\u2019s disease: A systematic scoping review of literature from 1937 to 2016","volume":"7","author":"Bature","year":"2017","journal-title":"BMJ Open"},{"key":"10.3233\/JAD-201418_ref6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.3233\/JAD-201418_ref7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.drudis.2016.02.012","article-title":"Animal disease models for drug screening: The elephant in the room?","volume":"21","author":"Tsukamoto","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.3233\/JAD-201418_ref8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3233\/JAD-150281","article-title":"A human-based integrated framework for Alzheimer\u2019s disease research","volume":"47","author":"Pistollato","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201418_ref9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/ani10071194","article-title":"Alzheimer\u2019s disease, and breast and prostate cancer research: Translational failures and the importance to monitor outputs and impact of funded research","volume":"10","author":"Pistollato","year":"2020","journal-title":"Animals"},{"key":"10.3233\/JAD-201418_ref10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1517\/13543784.16.8.1183","article-title":"Looking for novel ways to treat the hallmarks of Alzheimer\u2019s disease","volume":"16","author":"Stewart","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.3233\/JAD-201418_ref11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1523\/JNEUROSCI.4849-06.2007","article-title":"A\u03b240 inhibits amyloid depositionin vivo","volume":"27","author":"Kim","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201418_ref12","first-page":"198","article-title":"Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab","volume":"69","author":"Ostrowitzki","year":"2012","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-201418_ref13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-201418_ref14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.3233\/JAD-201418_ref15","first-page":"729","article-title":"Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment","volume":"60","author":"Guillozet","year":"2003","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-201418_ref16","first-page":"369808","article-title":"Alzheimer\u2019s disease and the amyloid cascade hypothesis: A critical review","volume":"2012","author":"Reitz","year":"2012","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-201418_ref17","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrn960","article-title":"Calcium dyshomeostasis and intracellular signalling in Alzheimer\u2019s disease","volume":"3","author":"LaFerla","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-201418_ref18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in Alzheimer\u2019s disease","volume":"4","author":"Huang","year":"2016","journal-title":"Biomed Rep"},{"key":"10.3233\/JAD-201418_ref19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-201418_ref20","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1017\/S146239941000150X","article-title":"Pathological implications of cell cycle re-entry in Alzheimer disease","volume":"12","author":"Bonda","year":"2010","journal-title":"Expert Rev Mol Med"},{"key":"10.3233\/JAD-201418_ref21","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s11064-014-1454-4","article-title":"Apoptosis in Alzheimer\u2019s disease: An understanding of the physiology, pathology and therapeutic avenues","volume":"39","author":"Obulesu","year":"2014","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-201418_ref22","doi-asserted-by":"crossref","first-page":"04","DOI":"10.3389\/fnagi.2018.00004","article-title":"Autophagy and Alzheimer\u2019s disease: From molecular mechanisms to therapeutic implications","volume":"10","author":"Uddin","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-201418_ref23","doi-asserted-by":"crossref","unstructured":"Marcello E , Epis R , Saraceno C , Di Luca M (2012) Synaptic dysfunction in Alzheimer\u2019s disease. In Synaptic Plasticity: Dynamics, Development and Disease, Kreutz MR, Sala C, eds. Springer Vienna, Vienna, pp. 573\u2013601.","DOI":"10.1007\/978-3-7091-0932-8_25"},{"key":"10.3233\/JAD-201418_ref24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.arr.2005.02.003","article-title":"Glucose metabolism and Alzheimer\u2019s disease","volume":"4","author":"Schubert","year":"2005","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-201418_ref25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrn3012","article-title":"Linking lipids to Alzheimer\u2019s disease: Cholesterol and beyond","volume":"12","author":"Di Paolo","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-201418_ref26","unstructured":"Martins IJ (2018) Advances in aging and health research. Scientific Research Publishing, Inc."},{"key":"10.3233\/JAD-201418_ref27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","article-title":"Insulin resistance and Alzheimer\u2019s disease: Bioenergetic linkages","volume":"9","author":"Neth","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-201418_ref28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","article-title":"A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer\u2019s disease","volume":"63","author":"Swerdlow","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.3233\/JAD-201418_ref29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fncel.2016.00024","article-title":"Alterations in mitochondrial quality control in Alzheimer\u2019s disease","volume":"10","author":"Cai","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-201418_ref30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbadis.2009.10.006","article-title":"Mitochondrial dysfunction is a trigger of Alzheimer\u2019s disease pathophysiology","volume":"1802","author":"Moreira","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-201418_ref31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fnagi.2015.00199","article-title":"The roles of lipid and glucose metabolism in modulation of \u03b2-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease","volume":"7","author":"Sato","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-201418_ref32","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s12035-014-9063-4","article-title":"The ubiquitin-proteasome system and molecular chaperone deregulation in Alzheimer\u2019s disease","volume":"53","author":"Sulistio","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-201418_ref33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bcp.2013.12.008","article-title":"Tau-aggregation inhibitor therapy for Alzheimer\u2019s disease","volume":"88","author":"Wischik","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-201418_ref34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13041-016-0261-z","article-title":"Amyloid \u03b2 oligomers elicit mitochondrial transport defects and fragmentation in a time-dependent and pathway-specific manner","volume":"9","author":"Rui","year":"2016","journal-title":"Mol Brain"},{"key":"10.3233\/JAD-201418_ref35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2009.07.003","article-title":"Amyloid deposition is associated with impaired default network function in older persons without dementia","volume":"63","author":"Sperling","year":"2009","journal-title":"Neuron"},{"key":"10.3233\/JAD-201418_ref36","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fnins.2019.00556","article-title":"A crosstalk between brain cholesterol oxidation and glucose metabolism in Alzheimer\u2019s disease","volume":"13","author":"Gamba","year":"2019","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-201418_ref37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2017.05.006","article-title":"Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity","volume":"179","author":"Bal-Price","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.3233\/JAD-201418_ref38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.drudis.2016.10.011","article-title":"Towards a 21st-century roadmap for biomedical research and drug discovery: Consensus report and recommendations","volume":"22","author":"Langley","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.3233\/JAD-201418_ref39","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.drudis.2018.05.038","article-title":"Recommendations toward a human pathway-based approach to disease research","volume":"23","author":"Marshall","year":"2018","journal-title":"Drug Discov Today"},{"key":"10.3233\/JAD-201418_ref40","unstructured":"Organisation for Economic Co-operation and Development (2016) Users\u2019 handbook supplement to the guidance document for developing and assessing adverse outcome pathways. InOECDSeries on Adverse OutcomePathways, No. 1, OECD Publishing, Paris."},{"key":"10.3233\/JAD-201418_ref42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cotox.2019.04.004","article-title":"Systems modeling of developmental vascular toxicity","volume":"15","author":"Saili","year":"2019","journal-title":"Curr Opin Toxicol"},{"key":"10.3233\/JAD-201418_ref43","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.yrtph.2015.04.004","article-title":"Increasing scientific confidence in adverse outcome pathways: Application of tailored Bradford-Hill considerations for evaluating weight of evidence","volume":"72","author":"Becker","year":"2015","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.3233\/JAD-201418_ref44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neuropharm.2010.04.005","article-title":"Oxidative stress in Alzheimer disease: A possibility for prevention","volume":"59","author":"Bonda","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-201418_ref45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fendo.2015.00013","article-title":"Insulin, aging, and the brain: Mechanisms and implications","volume":"6","author":"Akintola","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.3233\/JAD-201418_ref46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11357-011-9339-9","article-title":"High serum glucose levels are associated with a higher perceived age","volume":"35","author":"Noordam","year":"2013","journal-title":"Age"},{"key":"10.3233\/JAD-201418_ref47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2013.02.010","article-title":"Diabetes and altered glucose metabolism with aging","volume":"42","author":"Kalyani","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.3233\/JAD-201418_ref48","doi-asserted-by":"crossref","first-page":"180024","DOI":"10.1098\/rsob.180024","article-title":"Critical review: Involvement of endoplasmic reticulum stress in the aetiology of Alzheimer\u2019s disease","volume":"8","author":"Hashimoto","year":"2018","journal-title":"Open Biol"},{"key":"10.3233\/JAD-201418_ref49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-201418_ref50","doi-asserted-by":"crossref","first-page":"NS20180203","DOI":"10.1042\/NS20180203","article-title":"The role of APOE4 in Alzheimer\u2019s disease: Strategies for future therapeutic interventions","volume":"3","author":"Hunsberger","year":"2019","journal-title":"Neuronal Signal"},{"key":"10.3233\/JAD-201418_ref51","doi-asserted-by":"crossref","first-page":"26119","DOI":"10.1038\/srep26119","article-title":"ApoE4 expression accelerates hippocampus-dependent cognitive deficits by enhancing A\u03b2 impairment of insulin signaling in an Alzheimer\u2019s disease mouse model","volume":"6","author":"Chan","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-201418_ref52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-150348","article-title":"Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: Evidence of the mechanism of neuroprotection by ApoE2 and implications for Alzheimer\u2019s disease prevention and early intervention","volume":"48","author":"Keeney","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201418_ref53","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cmet.2010.11.006","article-title":"Diabetes and insulin in regulation of brain cholesterol metabolism","volume":"12","author":"Suzuki","year":"2010","journal-title":"Cell Metab"},{"key":"10.3233\/JAD-201418_ref54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","article-title":"Sugar for the brain: The role of glucose in physiological and pathological brain function","volume":"36","author":"Mergenthaler","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-201418_ref55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/156720512799015037","article-title":"Brain insulin resistance and deficiency as therapeutic targets in Alzheimer\u2019s disease","volume":"9","author":"de la Monte","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-201418_ref56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mad.2016.05.005","article-title":"Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer\u2019s disease brain","volume":"161","author":"Abolhassani","year":"2017","journal-title":"Mech Ageing Dev"},{"key":"10.3233\/JAD-201418_ref57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ph11010011","article-title":"The implication of the brain insulin receptor in late onset Alzheimer\u2019s disease dementia","volume":"11","author":"Folch","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.3233\/JAD-201418_ref58","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12433"},{"key":"10.3233\/JAD-201418_ref59","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1523\/JNEUROSCI.2243-10.2011","article-title":"Deletion of ERK1 and ERK2 in the CNS causes cortical abnormalities and neonatal lethality: Erk1 deficiency enhances the impairment of neurogenesis in Erk2-deficient mice","volume":"31","author":"Satoh","year":"2011","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201418_ref60","doi-asserted-by":"crossref","first-page":"4209475","DOI":"10.1155\/2019\/4209475","article-title":"GSK-3\u03b2 at the intersection of neuronal plasticity and neurodegeneration","volume":"2019","author":"Jaworski","year":"2019","journal-title":"Neural Plast"},{"key":"10.3233\/JAD-201418_ref61","first-page":"46","article-title":"GSK-3\u03b2, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Mart\u00edn","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-201418_ref62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tig.2017.10.002","article-title":"Keeping neurons young and foxy: FoxOs promote neuronal plasticity","volume":"34","author":"McLaughlin","year":"2018","journal-title":"Trends Genet"},{"key":"10.3233\/JAD-201418_ref63","first-page":"139","article-title":"Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?","volume":"46","author":"Blum-Degen","year":"1995","journal-title":"J Neural Transm Suppl"},{"key":"10.3233\/JAD-201418_ref64","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuropharm.2018.01.008","article-title":"Evidence for altered insulin receptor signaling in Alzheimer\u2019s disease","volume":"136","author":"Griffith","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-201418_ref65","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0047-6374(99)00118-9","article-title":"Insulin receptors in the brain cortex of aging mice","volume":"113","author":"Zaia","year":"2000","journal-title":"Mech Ageing Dev"},{"key":"10.3233\/JAD-201418_ref66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer\u2019s disease","volume":"105","author":"Fr\u00f6lich","year":"1998","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-201418_ref67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease \u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201418_ref68","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20160493","article-title":"Changes in insulin and insulin signaling in Alzheimer\u2019s disease: Cause or consequence?","volume":"213","author":"Stanley","year":"2016","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-201418_ref69","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1093\/cercor\/bht101","article-title":"Altered expression of diabetes-related genes in Alzheimer\u2019s disease brains: The Hisayama Study","volume":"24","author":"Hokama","year":"2013","journal-title":"Cereb Cortex"},{"key":"10.3233\/JAD-201418_ref70","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/neup.12095","article-title":"Down-regulation of MET in hippocampal neurons of Alzheimer\u2019s disease brains","volume":"34","author":"Hamasaki","year":"2014","journal-title":"Neuropathology"},{"key":"10.3233\/JAD-201418_ref71","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.bjp.0705494","article-title":"Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells","volume":"140","author":"Gerritsen","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JAD-201418_ref72","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3233\/JAD-2008-15412","article-title":"Potential mechanisms linking cholesterol to Alzheimer\u2019s disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle","volume":"15","author":"Ghribi","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201418_ref73","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00018-003-3018-7","article-title":"Cholesterol homeostasis and function in neurons of the central nervous system","volume":"60","author":"Pfrieger","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-201418_ref74","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1749-6632.2012.06513.x","article-title":"The link between altered cholesterol metabolism and Alzheimer\u2019s disease","volume":"1259","author":"Gamba","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-201418_ref75","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.15252\/embr.201439225","article-title":"Cholesterol in brain disease: Sometimes determinant and frequently implicated","volume":"15","author":"Mart\u00edn","year":"2014","journal-title":"EMBO Rep"},{"key":"10.3233\/JAD-201418_ref76","doi-asserted-by":"crossref","first-page":"17014","DOI":"10.1289\/EHP5053","article-title":"Screening ToxCast\u2122 for chemicals that affect cholesterol biosynthesis: Studies in cell culture and human induced pluripotent stem cell-derived neuroprogenitors","volume":"128","author":"Wages","year":"2020","journal-title":"Environ Health Perspect"},{"key":"10.3233\/JAD-201418_ref77","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jsbmb.2018.12.009","article-title":"On the fluxes of side-chain oxidized oxysterols across blood-brain and blood-CSF barriers and origin of these steroids in CSF (Review)","volume":"188","author":"Bj\u00f6rkhem","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.3233\/JAD-201418_ref78","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.nbd.2007.10.005","article-title":"Cholesterol retention in Alzheimer\u2019s brain is responsible for high \u03b2- and \u03b3-secretase activities and A\u03b2 production","volume":"29","author":"Xiong","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-201418_ref79","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s11011-017-0015-3","article-title":"Cholesterol as a modifying agent of the neurovascular unit structure and function under physiological and pathological conditions","volume":"32","author":"Czuba","year":"2017","journal-title":"Metab Brain Dis"},{"key":"10.3233\/JAD-201418_ref80","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1074\/jbc.M601019200","article-title":"24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates Apolipoprotein E-mediated cholesterol efflux","volume":"281","author":"Abildayeva","year":"2006","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201418_ref81","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.redox.2018.05.009","article-title":"A silver lining for 24-hydroxycholesterol in Alzheimer\u2019s disease: The involvement of the neuroprotective enzyme sirtuin 1","volume":"17","author":"Testa","year":"2018","journal-title":"Redox Biol"},{"key":"10.3233\/JAD-201418_ref82","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s11064-015-1524-2","article-title":"The oxysterol 27-hydroxycholesterol increases oxidative stress and regulate Nrf2 signaling pathway in astrocyte cells","volume":"40","author":"Ma","year":"2015","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-201418_ref83","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2217\/17460875.3.5.505","article-title":"Apolipoprotein E and cholesterol in aging and disease in the brain","volume":"3","author":"de Chaves","year":"2008","journal-title":"Future Lipidol"},{"key":"10.3233\/JAD-201418_ref84","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease: Pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-201418_ref85","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4103\/1673-5374.179044","article-title":"ApoE2 and Alzheimer\u2019s disease: Time to take a closer look","volume":"11","author":"Wu","year":"2016","journal-title":"Neural Regen Res"},{"key":"10.3233\/JAD-201418_ref86","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(01)03367-4","article-title":"Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein","volume":"928","author":"Nathan","year":"2002","journal-title":"Brain Res"},{"key":"10.3233\/JAD-201418_ref87","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0002-9440(10)64963-2","article-title":"Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice","volume":"156","author":"Tesseur","year":"2000","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-201418_ref88","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.nbd.2004.10.013","article-title":"Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology","volume":"18","author":"Wang","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-201418_ref89","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1326-8-34","article-title":"Cross-talk of membrane lipids and Alzheimer-related proteins","volume":"8","author":"Walter","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-201418_ref90","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1471-4159.1990.tb01889.x","article-title":"Lipid compositions of different regions of the human brain during aging","volume":"54","author":"S\u00f6derberg","year":"1990","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-201418_ref91","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0197-4580(92)90116-F","article-title":"Evidence for changes in the Alzheimer\u2019s disease brain cortical membrane structure mediated by cholesterol","volume":"13","author":"Mason","year":"1992","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-201418_ref92","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/jnc.12637","article-title":"Cholesterol as a causative factor in Alzheimer\u2019s disease: A debatable hypothesis","volume":"129","author":"Wood","year":"2014","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-201418_ref93","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-201418_ref94","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, Apolipoprotein Ee4 allele, and Alzheimer\u2019s disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JAD-201418_ref95","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1194\/jlr.M300320-JLR200","article-title":"Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer\u2019s disease","volume":"45","author":"Heverin","year":"2004","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-201418_ref96","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bcp.2012.12.007","article-title":"Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer\u2019s disease","volume":"86","author":"Popp","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-201418_ref97","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)32052-6","article-title":"Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients","volume":"41","author":"L\u00fctjohann","year":"2000","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-201418_ref98","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","article-title":"Brain cholesterol: Long secret life behind a barrier","volume":"24","author":"Bj\u00f6rkhem","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3233\/JAD-201418_ref99","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms, and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-201418_ref100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.febslet.2007.12.035","article-title":"Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease","volume":"582","author":"Liu","year":"2008","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-201418_ref101","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1590\/1980-57642015DN92000003","article-title":"Mechanisms linking brain insulin resistance to Alzheimer\u2019s disease","volume":"9","author":"Matioli","year":"2015","journal-title":"Dement Neuropsychol"},{"key":"10.3233\/JAD-201418_ref102","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-201418_ref103","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1523\/JNEUROSCI.23-18-07084.2003","article-title":"Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation","volume":"23","author":"Schubert","year":"2003","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201418_ref104","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0306-4522(00)00200-1","article-title":"Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons","volume":"99","author":"Lesort","year":"2000","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-201418_ref105","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1471-4159.1999.0720576.x","article-title":"Insulin transiently increases tau phosphorylation","volume":"72","author":"Lesort","year":"1999","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-201418_ref106","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.arr.2014.09.006","article-title":"Involvement of oxysterols in age-related diseases and ageing processes","volume":"18","author":"Zarrouk","year":"2014","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-201418_ref107","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1042\/BST20140164","article-title":"Hypercholesterolaemia-induced oxidative stress at the blood\u2013brain barrier","volume":"42","author":"Dias","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-201418_ref108","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","article-title":"Crossing the barrier: Oxysterols as cholesterol transporters and metabolic modulators in the brain","volume":"260","author":"Bjorkhem","year":"2006","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-201418_ref109","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/NEN.0000000000000103","article-title":"Tau pathology induces intraneuronal cholesterol accumulation","volume":"73","author":"Gl\u00f6ckner","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-201418_ref110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mcn.2017.07.002","article-title":"Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer\u2019s disease","volume":"83","author":"Theendakara","year":"2017","journal-title":"Mol Cell Neurosci"},{"key":"10.3233\/JAD-201418_ref111","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1042\/BST0381021","article-title":"Links between ApoE, brain cholesterol metabolism, tau and amyloid \u03b2-peptide in patients with cognitive impairment","volume":"38","author":"Leoni","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-201418_ref112","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/156720512799361682","article-title":"PP2A and Alzheimer disease","volume":"9","author":"Torrent","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-201418_ref113","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/exnr.2001.7630","article-title":"PP2A mRNA expression is quantitatively decreased in Alzheimer\u2019s disease hippocampus","volume":"168","author":"Vogelsberg-Ragaglia","year":"2001","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-201418_ref114","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.3233\/JAD-201418_ref115","doi-asserted-by":"crossref","first-page":"44795","DOI":"10.1074\/jbc.M408127200","article-title":"Increased tau phosphorylation in Apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: Modulation by zinc","volume":"279","author":"Harris","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201418_ref116","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice","volume":"24","author":"Brecht","year":"2004","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201418_ref117","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.1434398100","article-title":"Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer\u2019s disease-like neurodegeneration and behavioral deficits in transgenic mice","volume":"100","author":"Harris","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-201418_ref118","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-201418_ref119","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The role of oxidative stress in neurodegenerative diseases","volume":"24","author":"Kim","year":"2015","journal-title":"Exp Neurobiol"},{"key":"10.3233\/JAD-201418_ref120","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EC-14-0092","article-title":"Mitochondrial dysfunction and insulin resistance: An update","volume":"4","author":"Montgomery","year":"2014","journal-title":"Endocr Connect"},{"key":"10.3233\/JAD-201418_ref121","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/en.2011-1502","article-title":"PPAR\u03b3 agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets","volume":"153","author":"Pipatpiboon","year":"2012","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-201418_ref122","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.taap.2005.03.016","article-title":"Oxidative stress, mitochondrial permeability transition, and cell death in Cu-exposed trout hepatocytes","volume":"209","author":"Krumschnabel","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.3233\/JAD-201418_ref123","first-page":"2003","article-title":"Oxidative stress, mitochondrial damage and neurodegenerative diseases","volume":"8","author":"Guo","year":"2013","journal-title":"Neural Regen Res"},{"key":"10.3233\/JAD-201418_ref124","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2013.12.042","article-title":"Activity-driven local ATP synthesis is required for synaptic function","volume":"156","author":"Rangaraju","year":"2014","journal-title":"Cell"},{"key":"10.3233\/JAD-201418_ref125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopha.2015.07.025","article-title":"Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight","volume":"74","author":"Bhat","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"10.3233\/JAD-201418_ref126","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fendo.2018.00496","article-title":"Links between obesity-induced brain insulin resistance, brain mitochondrial dysfunction, and dementia","volume":"9","author":"Sripetchwandee","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.3233\/JAD-201418_ref127","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/jcb.26398","article-title":"Intranasal insulin treatment restores cognitive deficits and insulin signaling impairment induced by repeated methamphetamine exposure","volume":"119","author":"Beirami","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.3233\/JAD-201418_ref128","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3389\/fneur.2019.01168","article-title":"Mitochondrial cholesterol in Alzheimer\u2019s disease and Niemann-Pick Type C disease","volume":"10","author":"Torres","year":"2019","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-201418_ref129","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.3233\/JAD-2010-100498","article-title":"Reactive oxygen species: Stuck in the middle of neurodegeneration","volume":"20","author":"Patten","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201418_ref130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","article-title":"Oxidative stress in Alzheimer\u2019s disease","volume":"30","author":"Chen","year":"2014","journal-title":"Neurosci Bull"},{"key":"10.3233\/JAD-201418_ref131","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1432-1033.1989.tb14819.x","article-title":"Calcium chelator Quin 2 prevents hydrogen-peroxide-induced DNA breakage and cytotoxicity","volume":"182","author":"Cantoni","year":"1989","journal-title":"Eur J Biochem"},{"key":"10.3233\/JAD-201418_ref132","doi-asserted-by":"crossref","first-page":"e00034","DOI":"10.1042\/AN20100005","article-title":"The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass","volume":"2","author":"Uittenbogaard","year":"2010","journal-title":"ASN Neuro"},{"key":"10.3233\/JAD-201418_ref133","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/MN:31:1-3:205","article-title":"Oxidative imbalance in Alzheimer\u2019s disease","volume":"31","author":"Zhu","year":"2005","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-201418_ref134","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ggi.12659","article-title":"Differences in peripheral oxidative stress markers in Alzheimer\u2019s disease, vascular dementia and mixed dementia patients","volume":"15","author":"Hatanaka","year":"2015","journal-title":"Geriatr Gerontol Int"},{"key":"10.3233\/JAD-201418_ref135","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/ijms20020364","article-title":"Stress marks on the genome: Use or lose?","volume":"20","author":"Bokhari","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-201418_ref136","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s11064-011-0484-4","article-title":"Oxidative damage to RNA and expression patterns of MTH1 in the hippocampi of senescence-accelerated SAMP8 mice and Alzheimer\u2019s disease patients","volume":"36","author":"Song","year":"2011","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-201418_ref137","doi-asserted-by":"crossref","first-page":"e99897","DOI":"10.1371\/journal.pone.0099897","article-title":"Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer\u2019s disease","volume":"9","author":"Silva","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201418_ref138","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.freeradbiomed.2017.04.321","article-title":"P 236 - Oxidative stress markers of Alzheimer\u2019s disease in peripheral cell mitochondria","volume":"108","author":"Schoneich","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-201418_ref139","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/med.21534","article-title":"Involvement of calpain in the neuropathogenesis of Alzheimer\u2019s disease","volume":"39","author":"Mahaman","year":"2019","journal-title":"Med Res Rev"},{"key":"10.3233\/JAD-201418_ref140","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0006-8993(99)02148-4","article-title":"Oxidative stress and Ca2+influx upregulate calpain and induce apoptosis in PC12 cells","volume":"852","author":"Ray","year":"2000","journal-title":"Brain Res"},{"key":"10.3233\/JAD-201418_ref141","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(99)00960-X","article-title":"Activation of calpain precedes morphological alterations during hydrogen peroxide-induced apoptosis in neuronally differentiated mouse embryonal carcinoma P19 cell line","volume":"279","author":"Ishihara","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-201418_ref142","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.cdd.4401314","article-title":"Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons","volume":"11","author":"Amadoro","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.3233\/JAD-201418_ref143","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainres.2011.07.052","article-title":"Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer\u2019s disease","volume":"1415","author":"Reddy","year":"2011","journal-title":"Brain Res"},{"key":"10.3233\/JAD-201418_ref144","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3390\/ijms20081959","article-title":"Crosstalk between oxidative stress and tauopathy","volume":"20","author":"Haque","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-201418_ref145","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1371\/journal.pone.0000536","article-title":"Mitochondrial oxidative stress causes hyperphosphorylation of tau","volume":"2","author":"Melov","year":"2007","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201418_ref146","doi-asserted-by":"crossref","first-page":"14203","DOI":"10.1021\/bi001876l","article-title":"Oxidative regulation of fatty acid-induced tau polymerization","volume":"39","author":"Gamblin","year":"2000","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-201418_ref147","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201418_ref148","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fneur.2013.00083","article-title":"The importance of tau phosphorylation for neurodegenerative diseases","volume":"4","author":"Noble","year":"2013","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-201418_ref149","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/neuro.02.002.2009","article-title":"Crosstalk between Cdk5 and GSK3beta: Implications for Alzheimer\u2019s Disease","volume":"2","author":"Engmann","year":"2009","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-201418_ref150","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00018-007-7045-7","article-title":"Glycogen synthase kinase 3: A key regulator of cellular fate","volume":"64","author":"Forde","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-201418_ref151","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/35012636","article-title":"Neurotoxicity induces cleavage of p35 to p25 by calpain","volume":"405","author":"Lee","year":"2000","journal-title":"Nature"},{"key":"10.3233\/JAD-201418_ref152","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"key":"10.3233\/JAD-201418_ref153","doi-asserted-by":"crossref","first-page":"E4887","DOI":"10.1073\/pnas.1402627111","article-title":"CDK5 activator protein p25 preferentially binds and activates GSK3\u03b2","volume":"111","author":"Chow","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-201418_ref154","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/BJ20110347","article-title":"Glycogen synthase kinase-3\u03b2 regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src","volume":"437","author":"Yao","year":"2011","journal-title":"Biochem J"},{"key":"10.3233\/JAD-201418_ref155","doi-asserted-by":"crossref","first-page":"940603","DOI":"10.1155\/2013\/940603","article-title":"Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: Implications for Alzheimer\u2019s disease","volume":"2013","author":"Mondrag\u00f3n-Rodr\u00edguez","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.3233\/JAD-201418_ref156","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/sj.emboj.7600237","article-title":"A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons","volume":"23","author":"Morfini","year":"2004","journal-title":"EMBO J"},{"key":"10.3233\/JAD-201418_ref157","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer\u2019s disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"10.3233\/JAD-201418_ref158","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1242\/jcs.01558","article-title":"Tau phosphorylation in neuronal cell function and dysfunction","volume":"117","author":"Johnson","year":"2004","journal-title":"J Cell Sci"},{"key":"10.3233\/JAD-201418_ref159","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40478-016-0299-2","article-title":"Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer\u2019s disease brain","volume":"4","author":"Kurbatskaya","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-201418_ref160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2015\/151979","article-title":"Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative tauopathies?","volume":"2015","author":"Alavi Naini","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.3233\/JAD-201418_ref161","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.neurobiolaging.2005.05.005","article-title":"Oxidative modification and down-regulation of Pin1 in Alzheimer\u2019s disease hippocampus: A redox proteomics analysis","volume":"27","author":"Sultana","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-201418_ref162","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1460-9568.2006.04986.x","article-title":"Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy","volume":"24","author":"Cente","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JAD-201418_ref163","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau protein modifications and interactions: Their role in function and dysfunction","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-201418_ref164","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnagi.2017.00083","article-title":"Tau oligomers: Cytotoxicity, propagation, and mitochondrial damage","volume":"9","author":"Shafiei","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-201418_ref165","doi-asserted-by":"crossref","first-page":"23063","DOI":"10.1074\/jbc.M111.237974","article-title":"Characterization of prefibrillar tau oligomers in vitro and in Alzheimer disease","volume":"286","author":"Patterson","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201418_ref166","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"SantaCruz","year":"2005","journal-title":"Science"},{"key":"10.3233\/JAD-201418_ref167","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neures.2005.11.009","article-title":"Increased levels of granular tau oligomers: An early sign of brain aging and Alzheimer\u2019s disease","volume":"54","author":"Maeda","year":"2006","journal-title":"Neurosci Res"},{"key":"10.3233\/JAD-201418_ref168","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1021\/cn500148z","article-title":"The role of tau oligomers in the onset of Alzheimer\u2019s disease neuropathology","volume":"5","author":"C\u00e1rdenas-Aguayo","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-201418_ref169","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fneur.2013.00112","article-title":"Hyperphosphorylation-induced tau oligomers","volume":"4","author":"Iqbal","year":"2013","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-201418_ref170","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.11-199851","article-title":"Identification of oligomers at early stages of tau aggregation in Alzheimer\u2019s disease","volume":"26","author":"Lasagna-Reeves","year":"2012","journal-title":"FASEB J"},{"key":"10.3233\/JAD-201418_ref171","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fnagi.2014.00018","article-title":"Morphological and bioenergetic demands underlying the mitophagy in post-mitotic neurons: The pink-parkin pathway","volume":"6","author":"Amadoro","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-201418_ref172","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fnins.2019.00491","article-title":"Insulin and autophagy in neurodegeneration","volume":"13","author":"de Mello","year":"2019","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-201418_ref173","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1111\/bph.12453","article-title":"Quality control gone wrong: Mitochondria, lysosomal storage disorders and neurodegeneration","volume":"171","author":"Osellame","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JAD-201418_ref174","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuint.2017.08.004","article-title":"Mitophagy in neurodegenerative diseases","volume":"117","author":"Rodolfo","year":"2018","journal-title":"Neurochem Int"},{"issue":"suppl 2","key":"10.3233\/JAD-201418_ref175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000213726","article-title":"Age-related changes in the lipofuscin accumulation of brain and heart","volume":"41","author":"Nakano","year":"1995","journal-title":"Gerontology"},{"key":"10.3233\/JAD-201418_ref176","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/path.2094","article-title":"Autophagy, organelles and ageing","volume":"211","author":"Terman","year":"2007","journal-title":"J Pathol"},{"key":"10.3233\/JAD-201418_ref177","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0531-5565(00)00075-9","article-title":"When lysosomes get old","volume":"35","author":"Cuervo","year":"2000","journal-title":"Exp Gerontol"},{"issue":"suppl 2","key":"10.3233\/JAD-201418_ref178","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000213753","article-title":"The effect of age on formation and elimination of autophagic vacuoles in mouse hepatocytes","volume":"41","author":"Terman","year":"1995","journal-title":"Gerontology"},{"key":"10.3233\/JAD-201418_ref179","doi-asserted-by":"crossref","first-page":"14474","DOI":"10.1074\/jbc.M600364200","article-title":"Regulation of Intracellular Accumulation of Mutant Huntingtin by Beclin 1","volume":"281","author":"Shibata","year":"2006","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201418_ref180","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1073\/pnas.1009485107","article-title":"Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer\u2019s disease","volume":"107","author":"Lipinski","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-201418_ref181","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fnagi.2016.00229","article-title":"Sexual dimorphism and aging in the human hyppocampus: Identification, validation, and impact of differentially expressed genes by factorial microarray and network analysis","volume":"8","author":"Guebel","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-201418_ref182","doi-asserted-by":"crossref","first-page":"30441","DOI":"10.1074\/jbc.M115.677815","article-title":"BAG2 gene-mediated regulation of PINK1 protein is critical for mitochondrial translocation of PARKIN and neuronal survival","volume":"290","author":"Qu","year":"2015","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201418_ref183","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/45257","article-title":"Induction of autophagy and inhibition of tumorigenesis by beclin 1","volume":"402","author":"Liang","year":"1999","journal-title":"Nature"},{"key":"10.3233\/JAD-201418_ref184","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.freeradbiomed.2017.10.001","article-title":"Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer\u2019s Disease","volume":"114","author":"Colacurcio","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-201418_ref185","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1083\/jcb.200108057","article-title":"Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress","volume":"156","author":"Stamer","year":"2002","journal-title":"J Cell Biol"},{"key":"10.3233\/JAD-201418_ref186","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: Intracellular Abeta; and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-201418_ref187","first-page":"385","article-title":"Autophagy in Alzheimer\u2019s disease","volume":"26","author":"Zare-Shahabadi","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-201418_ref188","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jnc.13037","article-title":"Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): Analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD","volume":"133","author":"Tramutola","year":"2015","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-201418_ref189","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1111\/j.1742-4658.2005.04833.x","article-title":"Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer\u2019s disease brain","volume":"272","author":"Li","year":"2005","journal-title":"FEBS J"},{"key":"10.3233\/JAD-201418_ref190","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1074\/jbc.273.7.3963","article-title":"Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast","volume":"273","author":"Noda","year":"1998","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201418_ref191","doi-asserted-by":"crossref","first-page":"15556","DOI":"10.1074\/jbc.M112.435123","article-title":"Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: Implication for Alzheimer disease","volume":"288","author":"Tang","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201418_ref192","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.arr.2017.09.005","article-title":"Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases","volume":"40","author":"Moloudizargari","year":"2017","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-201418_ref193","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1093\/hmg\/ddp367","article-title":"Tau fragmentation, aggregation and clearance: The dual role of lysosomal processing","volume":"18","author":"Wang","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-201418_ref194","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1471-4159.2003.01642.x","article-title":"Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer\u2019s disease","volume":"85","author":"Keck","year":"2003","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-201418_ref195","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pharmthera.2012.07.001","article-title":"Tau as a therapeutic target in neurodegenerative disease","volume":"136","author":"Himmelstein","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.3233\/JAD-201418_ref196","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1523\/JNEUROSCI.1523-15.2015","article-title":"Internalized tau oligomers cause neurodegeneration by inducing accumulation of pathogenic tau in human neurons derived from induced pluripotent stem cells","volume":"35","author":"Usenovic","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201418_ref197","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1515\/tnsci-2015-0023","article-title":"Tau-mediated synaptic damage in Alzheimer\u2019s disease","volume":"6","author":"Jadhav","year":"2015","journal-title":"Transl Neurosci"},{"key":"10.3233\/JAD-201418_ref198","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-\u03b2 toxicity in Alzheimer\u2019s disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.3233\/JAD-201418_ref199","doi-asserted-by":"crossref","first-page":"32040","DOI":"10.1074\/jbc.M112.401240","article-title":"Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation","volume":"287","author":"Mondrag\u00f3n-Rodr\u00edguez","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201418_ref200","doi-asserted-by":"crossref","first-page":"19393","DOI":"10.1038\/srep19393","article-title":"Extracellular tau oligomers produce an immediate impairment of LTP and memory","volume":"6","author":"F\u00e1","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-201418_ref201","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.arcmed.2012.10.012","article-title":"Role of tau protein in neuronal damage in Alzheimer\u2019s disease and Down syndrome","volume":"43","author":"C\u00e1rdenas","year":"2012","journal-title":"Arch Med Res"},{"key":"10.3233\/JAD-201418_ref202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-201418_ref203","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1523\/JNEUROSCI.0587-07.2007","article-title":"Accumulation of pathological tau species and memory loss in a conditional model of tauopathy","volume":"27","author":"Berger","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201418_ref204","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1093\/brain\/awx256","article-title":"Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons","volume":"140","author":"Rodriguez-Rodriguez","year":"2017","journal-title":"Brain"},{"key":"10.3233\/JAD-201418_ref205","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1084\/jem.20161731","article-title":"Tau deletion promotes brain insulin resistance","volume":"214","author":"Marciniak","year":"2017","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-201418_ref206","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","article-title":"Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment","volume":"68","author":"Scheff","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JAD-201418_ref207","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcn.2015.12.001","article-title":"MicroRNA abundance is altered in synaptoneurosomes during prion disease","volume":"71","author":"Boese","year":"2016","journal-title":"Mol Cell Neurosci"},{"key":"10.3233\/JAD-201418_ref208","doi-asserted-by":"publisher","DOI":"10.5772\/54627."},{"key":"10.3233\/JAD-201418_ref209","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.3233\/JAD-201418_ref210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bj.2018.01.003","article-title":"Tau and neuroinflammation: What impact for Alzheimer\u2019s disease and tauopathies?","volume":"41","author":"Laurent","year":"2018","journal-title":"Biomed J"},{"key":"10.3233\/JAD-201418_ref211","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000322228","article-title":"Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation","volume":"8","author":"Bellucci","year":"2011","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-201418_ref212","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0002-9440(10)63421-9","article-title":"Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein","volume":"165","author":"Bellucci","year":"2004","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-201418_ref213","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3233\/JAD-160912","article-title":"Tau oligomers associate with inflammation in the brain and retina of tauopathy mice and in neurodegenerative diseases","volume":"55","author":"Nilson","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201418_ref214","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awt210","article-title":"Inflammatory components in human Alzheimer\u2019s disease and after active amyloid-\u03b242 immunization","volume":"136","author":"Zotova","year":"2013","journal-title":"Brain"},{"key":"10.3233\/JAD-201418_ref215","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/brain\/aww270","article-title":"Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy","volume":"140","author":"Laurent","year":"2017","journal-title":"Brain"},{"key":"10.3233\/JAD-201418_ref216","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00702-010-0438-z","article-title":"Neuroinflammatory processes in Alzheimer\u2019s disease","volume":"117","author":"Heneka","year":"2010","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-201418_ref217","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.3390\/ijms19123824","article-title":"The role of NADPH oxidases and oxidative stress in neurodegenerative disorders","volume":"19","author":"Tarafdar","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-201418_ref218","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbi.2017.01.020","article-title":"Markers of neuroinflammation associated with Alzheimer\u2019s disease pathology in older adults","volume":"62","author":"Popp","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-201418_ref219","first-page":"38","article-title":"Selective alterations of neurons and circuits related to early memory loss in Alzheimer\u2019s disease","volume":"8","author":"Llorens-Mart\u00edn","year":"2014","journal-title":"Front Neuroanat"},{"key":"10.3233\/JAD-201418_ref220","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: Synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201418_ref221","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00401-001-0477-5","article-title":"Neuron loss from the hippocampus of Alzheimer\u2019s disease exceeds extracellular neurofibrillary tangle formation","volume":"103","author":"Kril","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201418_ref222","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tem.2011.12.004","article-title":"Insulin resistance in the nervous system","volume":"23","author":"Kim","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.3233\/JAD-201418_ref223","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-201418_ref224","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.2337\/db15-0596","article-title":"Hippocampal insulin resistance impairs spatial learning and synaptic plasticity","volume":"64","author":"Grillo","year":"2015","journal-title":"Diabetes"},{"key":"10.3233\/JAD-201418_ref225","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.2353\/ajpath.2008.080528","article-title":"Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice","volume":"173","author":"Janelsins","year":"2008","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-201418_ref226","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z","article-title":"Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer\u2019s disease","volume":"379","author":"\u0160imi\u0107","year":"1997","journal-title":"J Comp Neurol"},{"key":"10.3233\/JAD-201418_ref227","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1034\/j.1600-0404.2003.00182.x","article-title":"No evidence for loss of hippocampal neurons in non-Alzheimer dementia patients","volume":"109","author":"Korbo","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-201418_ref228","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1093\/brain\/awt273","article-title":"Cell number changes in Alzheimer\u2019s disease relate to dementia, not to plaques and tangles","volume":"136","author":"Andrade-Moraes","year":"2013","journal-title":"Brain"},{"key":"10.3233\/JAD-201418_ref229","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00401-001-0475-7","article-title":"Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer\u2019s disease","volume":"103","author":"R\u00f6ssler","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201418_ref230","unstructured":"Organisation for Economic Co-operation and Development (2018) Users\u2019 handbook supplement to the guidance document for developing and assessing adverse outcome pathways. InOECDSeries on Adverse OutcomePathways, No. 1, OECD Publishing, Paris, Updated 2018."},{"key":"10.3233\/JAD-201418_ref231","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3233\/JAD-2012-121378","article-title":"Hyperhomocysteinemia in Alzheimer\u2019s disease: The hen and the egg?","volume":"33 4","author":"Farkas","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201418_ref232","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.diabres.2015.05.019","article-title":"The characteristic of cognitive function in Type 2 diabetes mellitus","volume":"109","author":"Gao","year":"2015","journal-title":"Diabetes Res Clin"},{"key":"10.3233\/JAD-201418_ref233","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.toxlet.2014.11.029","article-title":"The molecular mechanism of rotenone-induced \u03b1-synuclein aggregation: Emphasizing the role of the calcium\/GSK3\u03b2 pathway","volume":"233","author":"Yuan","year":"2015","journal-title":"Toxicol Lett"},{"key":"10.3233\/JAD-201418_ref234","doi-asserted-by":"crossref","first-page":"45465","DOI":"10.1038\/srep45465","article-title":"Mechanistic investigations of the mitochondrial complex I inhibitor rotenone in the context of pharmacological and safety evaluation","volume":"7","author":"Heinz","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-201418_ref235","doi-asserted-by":"crossref","first-page":"e5186","DOI":"10.1371\/journal.pone.0005186","article-title":"Chronic exposure to the herbicide, atrazine, causes mitochondrial dysfunction and insulin resistance","volume":"4","author":"Lim","year":"2009","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201418_ref236","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-4274(86)90144-X","article-title":"Effect of acute sublethal and chronic administration of ddt (chlorophenotane) on brain lipid metabolism of rhesus monkeys","volume":"34","author":"Sanyal","year":"1986","journal-title":"Toxicol Lett"},{"key":"10.3233\/JAD-201418_ref237","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfw041","article-title":"Identification of environmental quaternary ammonium compounds as direct inhibitors of cholesterol biosynthesis","volume":"151","author":"Herron","year":"2016","journal-title":"Toxicol Sci"},{"key":"10.3233\/JAD-201418_ref238","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s11745-008-3225-y","article-title":"CYP51: A major drug target in the cytochrome P450 superfamily","volume":"43","author":"Lepesheva","year":"2008","journal-title":"Lipids"},{"key":"10.3233\/JAD-201418_ref239","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.M900174-JLR200","article-title":"The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylasein vitro and in vivo","volume":"51","author":"Shafaati","year":"2010","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-201418_ref240","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1074\/jbc.M113.532846","article-title":"Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice","volume":"289","author":"Mast","year":"2014","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201418_ref241","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuropharm.2017.06.026","article-title":"Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer\u2019s disease","volume":"123","author":"Mast","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-201418_ref242","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1476-069X-12-108","article-title":"Analysis of the effects of exposure to polychlorinated biphenyls and chlorinated pesticides on serum lipid levels in residents of Anniston, Alabama","volume":"12","author":"Aminov","year":"2013","journal-title":"Environ Health"},{"key":"10.3233\/JAD-201418_ref243","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1124\/mol.117.110742","article-title":"Drugs and scaffold that inhibit cytochrome P450 27A1 in vitro and in vivo","volume":"93","author":"Lam","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.3233\/JAD-201418_ref244","doi-asserted-by":"crossref","first-page":"230261","DOI":"10.1155\/2013\/230261","article-title":"Effects of propofol, a sedative-hypnotic drug, on the lipid profile, antioxidant indices, and cardiovascular marker enzymes in wistar rats","volume":"2013","author":"Adaramoye","year":"2013","journal-title":"ISRN Pharmacol"},{"key":"10.3233\/JAD-201418_ref245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/1028415X.2018.1492772","article-title":"Crocin-protected malathion-induced spatial memory deficits by inhibiting TAU protein hyperphosphorylation and antiapoptotic effects","volume":"23","author":"Mohammadzadeh","year":"2020","journal-title":"Nutr Neurosci"},{"key":"10.3233\/JAD-201418_ref246","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/toxsci\/kfu247","article-title":"\u03b1-synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson\u2019s disease","volume":"143","author":"Harischandra","year":"2014","journal-title":"Toxicol Sci"},{"key":"10.3233\/JAD-201418_ref247","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.chemosphere.2018.11.149","article-title":"Fine particulate matter induces mitochondrial dysfunction and oxidative stress in human SH-SY5Y cells","volume":"218","author":"Wang","year":"2019","journal-title":"Chemosphere"},{"key":"10.3233\/JAD-201418_ref248","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cbi.2018.08.023","article-title":"Role of glutathione S-transferases in detoxification of a polycyclic aromatic hydrocarbon, methylcholanthrene","volume":"294","author":"Dasari","year":"2018","journal-title":"Chem Biol Interact"},{"key":"10.3233\/JAD-201418_ref249","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/15287394.2017.1314840","article-title":"Neurotoxicity of alkylated polycyclic aromatic compounds in human neuroblastoma cells","volume":"80","author":"Sarma","year":"2017","journal-title":"J Toxicol Environ Health Part A"},{"key":"10.3233\/JAD-201418_ref250","doi-asserted-by":"crossref","first-page":"e0129481","DOI":"10.1371\/journal.pone.0129481","article-title":"Polychlorinated biphenyls induce mitochondrial dysfunction in SH-SY5Y neuroblastoma cells","volume":"10","author":"Cocco","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201418_ref251","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.15419\/bmrat.v6i11.575","article-title":"Chemicals used for the induction of Alzheimer\u2019s disease-like cognitive dysfunctions in rodents","volume":"6","author":"Mahdi","year":"2019","journal-title":"Biomed Res Ther"},{"key":"10.3233\/JAD-201418_ref252","first-page":"242","article-title":"Neuroprotective effects of hydrogen sulfide on sodium azide-induced oxidative stress in PC12 cells","volume":"41","author":"Gao","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.3233\/JAD-201418_ref253","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tox.2008.10.006","article-title":"2,3,7,8-TCDD neurotoxicity in neuroblastoma cells is caused by increased oxidative stress, intracellular calcium levels, and tau phosphorylation","volume":"255","author":"Sul","year":"2009","journal-title":"Toxicology"},{"key":"10.3233\/JAD-201418_ref254","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-2012-111946","article-title":"Pesticides induce spatial memory deficits with synaptic impairments and an imbalanced tau phosphorylation in rats","volume":"30","author":"Chen","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201418_ref255","doi-asserted-by":"crossref","first-page":"26036","DOI":"10.1007\/s11356-020-08937-4","article-title":"Organophosphate toxicity: Updates of malathion potential toxic effects in mammals and potential treatments","volume":"27","author":"Badr","year":"2020","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.3233\/JAD-201418_ref256","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.toxlet.2014.05.009","article-title":"Uptake of silica nanoparticles: Neurotoxicity and Alzheimer-like pathology in human SK-N-SH and mouse neuro2a neuroblastoma cells","volume":"229","author":"Yang","year":"2014","journal-title":"Toxicol Lett"},{"key":"10.3233\/JAD-201418_ref257","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jes.2017.06.037","article-title":"Abnormal energy metabolism and tau phosphorylation in the brains of middle-aged mice in response to atmospheric PM2.5 exposure","volume":"62","author":"Gao","year":"2017","journal-title":"J Environ Sci"},{"key":"10.3233\/JAD-201418_ref258","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1039\/C6TX00314A","article-title":"Synergistic effects of particulate matter (PM2.5) and sulfur dioxide (SO2) on neurodegeneration via the microRNA-mediated regulation of tau phosphorylation","volume":"6","author":"Ku","year":"2017","journal-title":"Toxicol Res"},{"key":"10.3233\/JAD-201418_ref259","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4103\/1673-5374.153679","article-title":"Okadaic acid: A tool to study regulatory mechanisms for neurodegeneration and regeneration in Alzheimer\u2019s disease","volume":"10","author":"Kamat","year":"2015","journal-title":"Neural Regen Res"},{"key":"10.3233\/JAD-201418_ref260","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.toxlet.2011.01.030","article-title":"Akt\/GSK3\u03b2 signaling is involved in fipronil-induced apoptotic cell death of human neuroblastoma SH-SY5Y cells","volume":"202","author":"Lee","year":"2011","journal-title":"Toxicol Lett"},{"key":"10.3233\/JAD-201418_ref261","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.toxlet.2013.08.015","article-title":"Potential autophagy enhancers protect against fipronil-induced apoptosis in SH-SY5Y cells","volume":"223","author":"Park","year":"2013","journal-title":"Toxicol Lett"},{"key":"10.3233\/JAD-201418_ref262","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1744-9081-9-13","article-title":"The role of autophagy in Parkinson\u2019s disease: Rotenone-based modeling","volume":"9","author":"Nian","year":"2013","journal-title":"Behav Brain Funct"},{"key":"10.3233\/JAD-201418_ref263","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.taap.2013.01.013","article-title":"Autophagy regulates chlorpyrifos-induced apoptosis in SH-SY5Y cells","volume":"268","author":"Park","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.3233\/JAD-201418_ref264","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/tox.22116","article-title":"Autophagy potentially protects against 2,3,7,8-tetrachlorodibenzo- p -Dioxin induced apoptosis in SH-SY5Y cells","volume":"31","author":"Zhao","year":"2016","journal-title":"Environ Toxicol"},{"key":"10.3233\/JAD-201418_ref265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11010-006-9181-z","article-title":"Effect of tri-o-cresyl phosphate on cytoskeleton in human neuroblastoma SK-N-SH cell","volume":"290","author":"Chang","year":"2006","journal-title":"Mol Cell Biochem"},{"key":"10.3233\/JAD-201418_ref266","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tox.2013.05.012","article-title":"Induction of autophagy by TOCP in differentiated human neuroblastoma cells lead to degradation of cytoskeletal components and inhibition of neurite outgrowth","volume":"310","author":"Chen","year":"2013","journal-title":"Toxicology"},{"key":"10.3233\/JAD-201418_ref267","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2013.10.017","article-title":"Involvement of autophagy in tri-ortho-cresyl phosphate - Induced delayed neuropathy in hens","volume":"64","author":"Song","year":"2014","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-201418_ref268","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2131\/jts.38.823","article-title":"Methylmercury induces caspase-dependent apoptosis and autophagy in human neural stem cells","volume":"38","author":"Chang","year":"2013","journal-title":"J Toxicol Sci"},{"key":"10.3233\/JAD-201418_ref269","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbrc.2013.07.050","article-title":"Induction of cytoprotective autophagy in PC-12 cells by cadmium","volume":"438","author":"Wang","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-201418_ref270","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/toxsci\/kfr253","article-title":"Delayed reduction of hippocampal synaptic transmission and spines following exposure to repeated subclinical doses of organophosphorus pesticide in adult mice","volume":"125","author":"Speed","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.3233\/JAD-201418_ref271","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tox.2017.06.001","article-title":"Developmental exposure to glyphosate-based herbicide and depressive-like behavior in adult offspring: Implication of glutamate excitotoxicity and oxidative stress","volume":"387","author":"Cattani","year":"2017","journal-title":"Toxicology"},{"key":"10.3233\/JAD-201418_ref272","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tox.2014.03.001","article-title":"Mechanisms underlying the neurotoxicity induced by glyphosate-based herbicide in immature rat hippocampus: Involvement of glutamate excitotoxicity","volume":"320","author":"Cattani","year":"2014","journal-title":"Toxicology"},{"key":"10.3233\/JAD-201418_ref273","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12035-010-8146-0","article-title":"Molecular neurobiology of lead (Pb(2+)): Effects on synaptic function","volume":"42","author":"Neal","year":"2010","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-201418_ref274","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnmol.2013.00014","article-title":"Alcohol and NMDA receptor: Current research and future direction","volume":"6","author":"Chandrasekar","year":"2013","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-201418_ref275","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1523\/JNEUROSCI.19-09-03277.1999","article-title":"Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: Signal transduction cascades and site of ethanol action","volume":"19","author":"Bhave","year":"1999","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201418_ref276","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1742-2094-8-163","article-title":"Differential regional expression patterns of \u03b1-synuclein, TNF-\u03b1, and IL-1\u03b2; and variable status of dopaminergic neurotoxicity in mouse brain after Paraquat treatment","volume":"8","author":"Mitra","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-201418_ref277","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41514-018-0033-3","article-title":"Occupational-like organophosphate exposure disrupts microglia and accelerates deficits in a rat model of Alzheimer\u2019s disease","volume":"5","author":"Voorhees","year":"2019","journal-title":"NPJ Aging Mech Dis"},{"key":"10.3233\/JAD-201418_ref278","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s11064-013-1055-7","article-title":"Rotenone could activate microglia through NF\u03baB associated pathway","volume":"38","author":"Yuan","year":"2013","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-201418_ref279","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/toxsci\/kfp252","article-title":"Oxidative stress caused by ozone exposure induces loss of brain repair in the hippocampus of adult rats","volume":"113","author":"Rivas-Arancibia","year":"2010","journal-title":"Toxicol Sci"},{"key":"10.3233\/JAD-201418_ref280","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JAD-2011-110722","article-title":"Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults","volume":"28","author":"Calder\u00f3n-Garcidue\u00f1as","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201418_ref281","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.lfs.2012.03.012","article-title":"A study on neuroinflammatory marker in brain areas of okadaic acid (ICV) induced memory impaired rats","volume":"90","author":"Kamat","year":"2012","journal-title":"Life Sci"},{"key":"10.3233\/JAD-201418_ref282","first-page":"151","article-title":"Alcohol and Alzheimer\u2019s disease\u2014does alcohol dependence contribute to beta-amyloid deposition, neuroinflammation and neurodegeneration in Alzheimer\u2019s disease?","volume":"52","author":"Venkataraman","year":"2016","journal-title":"Alcohol Alcohol"},{"key":"10.3233\/JAD-201418_ref283","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-2094-5-10","article-title":"Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment","volume":"5","author":"Qin","year":"2008","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-201418_ref284","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.envres.2014.11.006","article-title":"Silver nanoparticles affect on gene expression of inflammatory and neurodegenerative responses in mouse brain neural cells","volume":"136","author":"Huang","year":"2015","journal-title":"Environ Res"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-201418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:05:34Z","timestamp":1777370734000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-201418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":281,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-201418","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]}}}